Showing results (1-10 of 511) with videos related to
Sort By:
Pageof 52
Der Internist|July 14, 2007
[Chronic renal failure and transplantation]U Kunzendorf, L Renders, E ZieglerClinical Pharmacology and Therapeutics|July 17, 2009
Increased mycophenolic acid exposure in stable kidney transplant recipients on tacrolimus as compared with those on sirolimus: implications for pharmacokineticsF Braun, H Schöcklmann, E Ziegler, et al.Der Internist|June 29, 2004
[Infections under immunosuppressive therapy following organ transplantation]L Renders, H Schöcklmann, U KunzendorfInternational Journal of Clinical Pharmacology and Therapeutics|November 19, 2003
Determination of the pharmacokinetics of cerivastatin when administered in combination with sirolimus and cyclosporin A in patients with kidney transplant, and review of the relevant literatureL Renders, D Czock, H Schöcklmann, et al.Kidney & Blood Pressure Research|January 1, 1996
Immunomodulation in experimental and clinical nephrology using chimeric proteinsU Kunzendorf, T Pohl, S Bulfone-Paus, et al.Transplantation Proceedings|July 15, 2004
"Very delayed" graft function in a patient after living related kidney transplantation: a case reportC Delles, C Schlüter, M Wittmann, et al.Clinical Pharmacology and Therapeutics|December 29, 2006
CYP3A5 genotype markedly influences the pharmacokinetics of tacrolimus and sirolimus in kidney transplant recipientsL Renders, M Frisman, M Ufer, et al.Journal of Cardiovascular Pharmacology|January 1, 1991
Renal protection with the calcium antagonistsH H Neumayer, U KunzendorfDer Urologe. Ausg. A|June 5, 2019
[Reasons for the low organ donation rate in Germany]K Schulte, U Kunzendorf, T FeldkampKidney International. Supplement|May 1, 1992
Protective effects of calcium antagonists in human renal transplantationH H Neumayer, U Kunzendorf, M SchreiberPageof 52